1. PS5:101 Nuclear antigen-reactive cd4+ t cells are expanded in active sle, correlate with disease activity, invade target organs such as the kidneys, and outnumber their regulatory counterparts. (21st March 2018) Authors: Abdirama, D; Tesch, S; Griessbach, A-S; Scheffold, A; Radbruch, A; Stervbo, U; Babel, N; Burmester, G-R; Humrich, JY; Riemekasten, G; Enghard, P Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 1 Page Start: A86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A7.06 Low-dose IL-2 therapy in refractory sle: Insights from a phase I/IIA clinical trial. (24th February 2016) Authors: Humrich, JY; von Spee-Mayer, C; Siegert, E; Bertolo, M; Abdirama, D; Rose, A; Enghard, P; Radbruch, A; Burmester, GR; Riemekasten, G Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A2.17 Detection of autoantigen-specific CD4+ T cells associated with systemic lupus erythematosus. (24th February 2016) Authors: Abdirama, D; Enghard, P; Tesch, S; Radbruch, A; Burmester, GR; Riemekasten, G Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P134/O32 Selective expansion of a thymic-derived and functionally competent regulatory T cell population by low-dose IL-2 therapy in patients with refractory SLE. (March 2019) Authors: Humrich, JY; von Spee-Mayer, C; Siegert, E; Bertolo, M; Rose, A; Abdirama, D; Enghard, P; Stuhlmüller, B; Hiepe, F; Alexander, T; Feist, E; Radbruch, A; Burmester, G-R; Riemekasten, G Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗